The increase of GSK3β activity induced by NC1(XIX), through a GSK3β dephosphorylation process, could explain the effects of NC1(XIX) on mTOR inhibition and could also explain its anti-tumor effects on SK-MEL-28 and other melanoma cell lines previously described [15, 16]. The gene discussed is GSK3B; the disease is melanoma.